Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study.

Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, Assfalg R, Weininger K, Wittich S, Löbner S, Beyerlein A, Nennstiel-Ratzel U, Lang M, Laub O, Dunstheimer D, Bonifacio E, Achenbach P, Winkler C, Ziegler AG; Fr1da Study Group.

BMJ Open. 2016 May 18;6(5):e011144. doi: 10.1136/bmjopen-2016-011144.

2.

Doublesex and mab-3 related transcription factor 1 (DMRT1) is a sex-specific genetic determinant of childhood-onset asthma and is expressed in testis and macrophages.

Schieck M, Schouten JP, Michel S, Suttner K, Toncheva AA, Gaertner VD, Illig T, Lipinski S, Franke A, Klintschar M, Kalayci O, Sahiner UM, Birben E, Melén E, Pershagen G, Freidin MB, Ogorodova LM, Granell R, Henderson J, Brunekreef B, Smit HA, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Genuneit J, Jonigk D, Postma DS, Koppelman GH, Vonk JM, Timens W, Boezen HM, Kabesch M.

J Allergy Clin Immunol. 2016 Aug;138(2):421-31. doi: 10.1016/j.jaci.2015.12.1305. Epub 2016 Feb 20.

PMID:
26906082
3.

Childhood asthma is associated with mutations and gene expression differences of ORMDL genes that can interact.

Toncheva AA, Potaczek DP, Schedel M, Gersting SW, Michel S, Krajnov N, Gaertner VD, Klingbeil JM, Illig T, Franke A, Winkler C, Hohlfeld JM, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Genuneit J, Muntau AC, Kabesch M.

Allergy. 2015 Oct;70(10):1288-99. doi: 10.1111/all.12652. Epub 2015 Jul 20.

PMID:
26011647
4.

Polymorphisms related to ORMDL3 are associated with asthma susceptibility, alterations in transcriptional regulation of ORMDL3, and changes in TH2 cytokine levels.

Schedel M, Michel S, Gaertner VD, Toncheva AA, Depner M, Binia A, Schieck M, Rieger MT, Klopp N, von Berg A, Bufe A, Laub O, Rietschel E, Heinzmann A, Simma B, Vogelberg C, Genuneit J, Illig T, Kabesch M.

J Allergy Clin Immunol. 2015 Oct;136(4):893-903.e14. doi: 10.1016/j.jaci.2015.03.014. Epub 2015 Apr 28.

PMID:
25930191
5.

Fine-mapping of IgE-associated loci 1q23, 5q31, and 12q13 using 1000 Genomes Project data.

Sharma V, Michel S, Gaertner V, Franke A, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, Zeilinger S, Illig T, Schedel M, Potaczek DP, Kabesch M.

Allergy. 2014 Aug;69(8):1077-84. doi: 10.1111/all.12431. Epub 2014 Jun 14.

PMID:
24930997
6.

A role of FCER1A and FCER2 polymorphisms in IgE regulation.

Sharma V, Michel S, Gaertner V, Franke A, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, Potaczek DP, Kabesch M.

Allergy. 2014 Feb;69(2):231-6. doi: 10.1111/all.12336. Epub 2013 Dec 20.

PMID:
24354852
7.

Genetic variation in TH17 pathway genes, childhood asthma, and total serum IgE levels.

Schieck M, Michel S, Suttner K, Illig T, Zeilinger S, Franke A, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, Kerzel S, Kabesch M.

J Allergy Clin Immunol. 2014 Mar;133(3):888-91. doi: 10.1016/j.jaci.2013.08.048. Epub 2013 Nov 1. No abstract available.

PMID:
24184148
8.

Polymorphisms in the IRF-4 gene, asthma and recurrent bronchitis in children.

Pinto LA, Michel S, Klopp N, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Simma B, Frischer T, Genuneit J, Gorski M, Illig T, Kabesch M.

Clin Exp Allergy. 2013 Oct;43(10):1152-9. doi: 10.1111/cea.12175.

PMID:
24074333
9.

Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics.

Potaczek DP, Michel S, Sharma V, Zeilinger S, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, Illig T, Kabesch M.

Pediatr Allergy Immunol. 2013 Aug;24(5):441-9. doi: 10.1111/pai.12083. Epub 2013 Jun 3.

PMID:
23725541
10.

Polymorphisms in extracellular signal-regulated kinase family influence genetic susceptibility to asthma.

Pandey RC, Michel S, Schieck M, Binia A, Liang L, Klopp N, Franke A, von Berg A, Bufe A, Rietschel E, Heinzmann A, Laub O, Simma B, Frischer T, Genuneit J, Illig T, Kabesch M.

J Allergy Clin Immunol. 2013 Apr;131(4):1245-7. doi: 10.1016/j.jaci.2012.12.675. Epub 2013 Feb 4. No abstract available.

PMID:
23384682
11.

Genetic variation in the Toll-like receptor signaling pathway is associated with childhood asthma.

Pandey RC, Michel S, Tesse R, Binia A, Schedel M, Liang L, Klopp N, Franke A, von Berg A, Bufe A, Rietschel E, Heinzmann A, Laub O, Simma B, Frischer T, Genuneit J, Illig T, Kabesch M.

J Allergy Clin Immunol. 2013 Feb;131(2):602-5. doi: 10.1016/j.jaci.2012.10.061. Epub 2012 Dec 28. No abstract available.

PMID:
23273951
12.

Genetic variants in Protocadherin-1, bronchial hyper-responsiveness, and asthma subphenotypes in German children.

Toncheva AA, Suttner K, Michel S, Klopp N, Illig T, Balschun T, Vogelberg C, von Berg A, Bufe A, Heinzmann A, Laub O, Rietschel E, Simma B, Frischer T, Genuneit J, von Mutius E, Kabesch M.

Pediatr Allergy Immunol. 2012 Nov;23(7):636-41. doi: 10.1111/j.1399-3038.2012.01334.x. Epub 2012 Oct 11.

PMID:
23050600
13.

Fingerprint-imprinted polymer: rational selection of peptide epitope templates for the determination of proteins by molecularly imprinted polymers.

Bossi AM, Sharma PS, Montana L, Zoccatelli G, Laub O, Levi R.

Anal Chem. 2012 May 1;84(9):4036-41. doi: 10.1021/ac203422r. Epub 2012 Apr 17.

PMID:
22462546
14.

Unifying candidate gene and GWAS Approaches in Asthma.

Michel S, Liang L, Depner M, Klopp N, Ruether A, Kumar A, Schedel M, Vogelberg C, von Mutius E, von Berg A, Bufe A, Rietschel E, Heinzmann A, Laub O, Simma B, Frischer T, Genuneit J, Gut IG, Schreiber S, Lathrop M, Illig T, Kabesch M.

PLoS One. 2010 Nov 12;5(11):e13894. doi: 10.1371/journal.pone.0013894.

15.

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.

Ben-Nathan D, Gershoni-Yahalom O, Samina I, Khinich Y, Nur I, Laub O, Gottreich A, Simanov M, Porgador A, Rager-Zisman B, Orr N.

BMC Infect Dis. 2009 Feb 17;9:18. doi: 10.1186/1471-2334-9-18.

16.

Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.

Lustig S, Maik-Rachline G, Paran N, Melamed S, Israely T, Erez N, Orr N, Reuveny S, Ordentlich A, Laub O, Shafferman A, Velan B.

Vaccine. 2009 Mar 10;27(11):1691-9. doi: 10.1016/j.vaccine.2009.01.038. Epub 2009 Feb 3.

PMID:
19195492
17.

Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.

Fuchs S, Feferman T, Meidler R, Margalit R, Sicsic C, Brenner T, Laub O, Souroujon MC.

Ann N Y Acad Sci. 2008;1132:244-8. doi: 10.1196/annals.1405.032.

PMID:
18567875
18.
19.

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.

Fuchs S, Feferman T, Meidler R, Margalit R, Sicsic C, Wang N, Zhu KY, Brenner T, Laub O, Souroujon MC.

J Neuroimmunol. 2008 Feb;194(1-2):89-96. doi: 10.1016/j.jneuroim.2007.11.020. Epub 2008 Feb 21.

PMID:
18178258
20.

Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.

Fuchs S, Feferman T, Zhu KY, Meidler R, Margalit R, Wang N, Laub O, Souroujon MC.

Ann N Y Acad Sci. 2007 Sep;1110:550-8.

PMID:
17911471
21.

[Asthma training in children and adolescents].

Laub O.

Fortschr Med Orig. 2000 Jul 27;118 Suppl 2:71-5. German.

PMID:
15700489
22.

[Asthma education for children and adolescents. 4 good reasons for program implementation].

Laub O.

MMW Fortschr Med. 2000 Jun 8;142(23):35. German. No abstract available.

PMID:
10900950
23.

Estrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells.

Almog Y, Klein A, Adler R, Laub O, Tur-Kaspa R.

Antiviral Res. 1992 Oct 1;19(4):285-93.

PMID:
1463321
24.

In vitro regulation of human hepatitis B virus core gene transcription.

Waisman A, Aloni Y, Laub O.

Virology. 1990 Aug;177(2):737-44.

PMID:
2371776
25.
26.

Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription.

Tur-Kaspa R, Teicher L, Laub O, Itin A, Dagan D, Bloom BR, Shafritz DA.

J Virol. 1990 Apr;64(4):1821-4.

27.
28.
30.
32.

Homologous recombination between a defective virus and a chromosomal sequence in mammalian cells.

Shaul Y, Laub O, Walker MD, Rutter WJ.

Proc Natl Acad Sci U S A. 1985 Jun;82(11):3781-4.

33.

A human hepatitis B viral enhancer element.

Shaul Y, Rutter WJ, Laub O.

EMBO J. 1985 Feb;4(2):427-30.

34.

Hepatitis B virus encodes an RNA polymerase III transcript.

Standring DN, Rall LB, Laub O, Rutter WJ.

Mol Cell Biol. 1983 Oct;3(10):1774-82.

35.

Transcription of hepatitis B virus by RNA polymerase II.

Rall LB, Standring DN, Laub O, Rutter WJ.

Mol Cell Biol. 1983 Oct;3(10):1766-73.

36.

Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region.

Laub O, Rall LB, Truett M, Shaul Y, Standring DN, Valenzuela P, Rutter WJ.

J Virol. 1983 Oct;48(1):271-80.

37.

Expression of the human insulin gene and cDNA in a heterologous mammalian system.

Laub O, Rutter WJ.

J Biol Chem. 1983 May 25;258(10):6043-50.

38.

Expression of the human insulin gene in an alternate mammalian cell and in cell extracts.

Laub O, Rall L, Bell GI, Rutter WJ.

J Biol Chem. 1983 May 25;258(10):6037-42.

39.

The metabolism of SV40 RNA is associated with the cytoskeletal framework.

Ben-Ze'ev A, Horowitz M, Skolnik H, Abulafia R, Laub O, Aloni Y.

Virology. 1981 Jun;111(2):475-87. No abstract available.

PMID:
6264669
40.
41.

Mechanism for circularization of MVM DNA by "noose" sliding in a lassolike structure: implication for integration.

Aloni Y, Bratosin S, Laub O, Tal J.

Cold Spring Harb Symp Quant Biol. 1980;44 Pt 1,:585-90. No abstract available.

PMID:
6933046
42.
43.

Transcription of the cellular DNA sequences in a cloned host-substituted SV40 DNA variant.

Hartman JR, Laub O, Aloni Y, Winocour E.

Virology. 1979 Apr 15;94(1):82-94. No abstract available.

PMID:
220790
44.

The initiation of transcription of SV40 DNA at late time after infection.

Laub O, Bratosin S, Horowitz M, Aloni Y.

Virology. 1979 Jan 30;92(2):310-23. No abstract available.

PMID:
218346
45.

Splicing of SV40 late mRNA is a post-transcriptional process.

Horowitz M, Laub O, Bratosin S, Aloni Y.

Nature. 1978 Oct 12;275(5680):558-9. No abstract available.

PMID:
211442
46.

The frequencies of transcription from the E- and L-strands of polyoma DNA.

Bar-Shavit R, Laub O, Aloni Y.

J Gen Virol. 1978 May;39(2):357-60.

PMID:
206660
47.

Electron microscopic evidence for splicing of SV40 late mRNAs.

Bratosin S, Horowitz M, Laub O, Aloni Y.

Cell. 1978 Apr;13(4):783-90.

PMID:
207441
48.

Splicing of SV40 mRNAs: a novel mechanism for the regulation of gene expression in animal cells.

Aloni Y, Bratosin S, Dhar R, Laub O, Horowitz M, Khoury G.

Cold Spring Harb Symp Quant Biol. 1978;42 Pt 1:559-70. No abstract available.

PMID:
209945
49.
50.

Supplemental Content

Support Center